世界の高トリグリセリド血症市場2021年-2027年:種類別、治療別、エンドユーザー別、流通チャネル別、地域別

■ 英語タイトル:Hypertriglyceridemia Market with COVID-19 Impact Analysis, By Type, By Treatment, By End-user, By Distribution Channel, and By Region – Size, Share, & Forecast from 2021-2027

調査会社AnalystView Market Insights社が発行したリサーチレポート(データ管理コード:AVEW21JN123)■ 発行会社/調査会社:AnalystView Market Insights
■ 商品コード:AVEW21JN123
■ 発行日:2020年12月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:270
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Five User(5名様閲覧)USD4,650 ⇒換算¥688,200見積依頼/購入/質問フォーム
Enterprise User(法人閲覧用)USD5,650 ⇒換算¥836,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
AnalystView Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の高トリグリセリド血症市場2021年-2027年:種類別、治療別、エンドユーザー別、流通チャネル別、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Analyst View社の本調査レポートでは、世界の高トリグリセリド血症市場について調査・分析し、市場概要、エグゼクティブサマリー、市場動向、市場調査、新型コロナウイルス感染症の影響、市場状況、種類別(原発性高トリグリセリド血症、続発性高トリグリセリド血症、その他)分析、治療別(薬理学、フィブラート、スタチン、ナイアシン、その他)分析、エンドユーザー別(病院、専門クリニック、ホームケア、その他)分析、流通チャンネル別(病院薬局、小売薬局、オンライン薬局、その他)分析、地域別分析、主要企業分析、360度アナリストビューなどの項目を掲載しています。
・市場概要
・エグゼクティブサマリー
・市場動向
・市場調査
・新型コロナウイルス感染症の影響
・市場状況
・世界の高トリグリセリド血症市場規模:種類別(原発性高トリグリセリド血症、続発性高トリグリセリド血症、その他)
・世界の高トリグリセリド血症市場規模:治療別(薬理学、フィブラート、スタチン、ナイアシン、その他)
・世界の高トリグリセリド血症市場規模:エンドユーザー別(病院、専門クリニック、ホームケア、その他)
・世界の高トリグリセリド血症市場規模:流通チャンネル別(病院薬局、小売薬局、オンライン薬局、その他)
・世界の高トリグリセリド血症市場規模:地域別
・主要企業分析
・360度アナリストビュー

REPORT HIGHLIGHT
The global hypertriglyceridemia market was valued at USD 9.82 billion by 2019, growing with 5.6% CAGR during the forecast period, 2021-2027.

Hypertriglyceridemia is a disorder in which triglyceride levels are elevated. Elevated triglycerides are determined by direct laboratory analysis of plasma or serum after a 10- to 12-hour fast. It is mainly caused by uncontrolled obesity, diabetes mellitus, and sedentary habits. It is more prevalent in the United States and in industrialized societies than in emerging nations. The growing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD) is likely to boost the growth of the global hypertriglyceridemia market. For instance, according to the American College of Cardiology, coronary artery disease (CAD) estimates for the highest cause of morbidity and mortality in the U.S. More than 42 percent of patients with CAD also have peripheral artery disease (PAD). Additionally, unhealthy lifestyles and increased cases of atherogenic dyslipidemia are anticipated to support the expansion of the overall hypertriglyceridemia market in the near future.

Furthermore, growth in the geriatric visits in ASC and outpatient facilities is estimated to account for the robust growth of the hypertriglyceridemia market in the upcoming years. On the other hand, strategies undertaken by the leading manufacturer to develop and launch more advanced hypertriglyceridemia therapeutics is projected to create significant growth opportunities for the market in the near future. For instance, in November 2020, Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, launched Icosapent Ethyl Capsules, 1gm, in the US. This Hikma’s FDA-approved Icosapent Ethyl Capsule product is indicated to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Further, in March 2020, Zydus Cadila gets the DCGI nod for Saroglitazar to treat liver disease. Saroglitazar was launched in September 2013 in India, for the treatment of hypertriglyceridemia and diabetic dyslipidemia. In addition, in September 2020, 89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases announced the initiation of a Phase 2 trial evaluating its product candidate BIO89-100 in patients with severe hypertriglyceridemia. BIO89-100 is a glycoPEGylated analog of fibroblast growth factor 21 (“FGF21”) in clinical development for the treatment of non-alcoholic steatohepatitis (“NASH”) and SHTG.

However, unfavourable reimbursement scenario and the high cost of hypertriglyceridemia therapeutics is predicted to hamper the growth of the target market. Moreover, the lack of medical care in developing economies might also sluggish the growth of the business market. Geographically, North America dominates the hypertriglyceridemia market in terms of the highest revenue share. The backside is mainly attributed because of the availability of higher antibiotics and advancement in drug designing. Besides, rising awareness about antibiotic-associated conditions, higher adoption of junk foods, and an increase in hospital-acquired infection awareness coupled with the supporting regulatory policies have enhanced the monitoring scenario for the North American hypertriglyceridemia market.

Key features of the study:
• This proposed research study on Hypertriglyceridemia market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Hypertriglyceridemia market
• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Hypertriglyceridemia market
• Impact of COVID-19 on Hypertriglyceridemia market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Hypertriglyceridemia market post-COVID will also be covered.
• In order to give the users of this report a comprehensive view on the Hypertriglyceridemia market, we have also included competitive landscape and key innovator analysis for the Hypertriglyceridemia market.
• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and Treatment’s attractiveness.
• The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Hypertriglyceridemia market.
• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Hypertriglyceridemia market on global as well as regional level.
• The global Hypertriglyceridemia market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HYPERTRIGLYCERIDEMIA MARKET KEY PLAYERS
 Sanofi
 GlaxoSmithKline Plc
 Biocon
 Novo Nordisk A/S
 Tonghua Dongbao Pharmaceutical Co., Ltd.
 Oramed Pharmaceuticals, Inc.
 Bristol-Myers Squibb Company
 Merck & Co., Inc.
 Julphar
 Eli Lilly and Company
 Pfizer Inc.
 Adocia
 Hikma Pharmaceutical PLC
 Lupin Ltd.
 Wockhardt
 Zydus Pharmaceuticals Inc.
 AbbVie Inc.
 Glenmark
 Amneal pharmaceutical LLC
 Aurobindo Pharma
 Accord Healthcare

GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY TYPE
 Primary Hypertriglyceridemia
 Secondary Hypertriglyceridemia
 Others

GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY TREATMENT
 Pharmacological
o Fibrates
o Statins
o Niacin
o Other Lipid-Lowering Medications
 Non-Pharmacological
o Lifestyle Changes
o Dietary Modification
o Exercise
o Others
 Emerging Treatments
o Rimonabant
o Glitazar Drugs
o LPL Gene Therapy
o Others
 Others

GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY END-USER
 Hospitals
 Specialty Clinics
 Homecare
 Others

GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY DISTRIBUTION CHANNEL
 Hospital Pharmacy
 Retail Pharmacy
 Online Pharmacy
 Others

GLOBAL HYPERTRIGLYCERIDEMIA MARKET, BY REGION
 North America
o The U.S.
o Canada
 Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Rest of Europe
 Asia Pacific
o India
o China
o South Korea
o Japan
o Singapore
o Rest of APAC
 Latin America
o Brazil
o Mexico
o Argentina
o Rest of LATAM
 The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Rest of MEA

*** レポート目次(コンテンツ)***

TABLE OF CONTENT
1. Hypertriglyceridemia Market Overview
• Study Scope
2. Executive Summary
• Market Snippet
• Market Snippet by Type
• Market Snippet by Treatment
• Market Snippet by End-user
• Market Snippet by Distribution Channel
• Market Snippet by Region
• Competitive Insights
3. Hypertriglyceridemia Key Market Trends
• Market Drivers
• Impact Analysis of Market Drivers
• Market Restraints
• Impact Analysis of Market Restraints
• Market Opportunities
• Market Future Trends
4. Hypertriglyceridemia Industry Study
• Porter’s Five Forces Analysis
• Marketing Strategy Analysis
• Growth Prospect Mapping
• Regulatory Framework Analysis
5. Hypertriglyceridemia Market : COVID-19 Impact Analysis
• Pre-COVID-19 Impact Analysis
• Post-COVID-19 Impact Analysis
• Top Performing Segments
• Marginal Growth Segments
• Top Looser Segments
• Marginal Loss Segments
6. Hypertriglyceridemia Market Landscape
• Market Share Analysis, 2019
• Key Innovators Analysis
• Breakdown Data, by Key Manufacturer
• Established Players’ Analysis
• Emerging Players’ Analysis
7. Hypertriglyceridemia Market – By Type
• Overview
• Segment Share Analysis, By Type, 2020 & 2027 (%)
• Primary Hypertriglyceridemia
• Secondary Hypertriglyceridemia
• Others
8. Hypertriglyceridemia Market – By Treatment
• Overview
• Segment Share Analysis, By Treatment, 2020 & 2027 (%)
• Pharmacological
• Fibrates
• Statins
• Niacin
• Other Lipid-Lowering Medications
• Non-Pharmacological
• Lifestyle Changes
• Dietary Modification
• Exercise
• Others
• Emerging Treatments
• Rimonabant
• Glitazar Drugs
• LPL Gene Therapy
• Others
• Others
9. Hypertriglyceridemia Market – By End-user
• Overview
• Segment Share Analysis, By Treatment, 2020 & 2027 (%)
• Hospitals
• Specialty Clinics
• Homecare
• Others
10. Hypertriglyceridemia Market – By Distribution Channel
• Overview
• Segment Share Analysis, By Treatment, 2020 & 2027 (%)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
11. Hypertriglyceridemia Market – By Geography
• Introduction
• Segment Share Analysis, By Geography, 2020 & 2027 (%)
• North America
• Overview
• Key Manufacturers in North America
• North America Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
• North America Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• North America Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• North America Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• North America Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• U.S.
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• U.S. Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• U.S. Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• U.S. Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• U.S. Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Canada
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Canada Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Canada Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Canada Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Canada Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Europe
• Overview
• Key Manufacturers in Europe
• Europe Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
• Europe Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Europe Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Europe Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Europe Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Germany
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Germany Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Germany Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Germany Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Germany Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Italy
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Italy Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Italy Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Italy Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Italy Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• United Kingdom
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• United Kingdom Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• United Kingdom Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• United Kingdom Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• United Kingdom Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• France
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• France Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• France Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• France Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• France Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Rest of Europe
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Rest of the Europe Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Rest of the Europe Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Rest of the Europe Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Asia Pacific (APAC)
• Overview
• Key Manufacturers in Asia Pacific
• Asia Pacific Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
• Asia Pacific Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Asia Pacific Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Asia Pacific market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• India
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• India Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• India Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• India Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• India Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• China
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• China Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• China Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• China Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• China Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Japan
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Japan Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Japan Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Japan Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Japan Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• South Korea
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• South Korea Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• South Korea Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• South Korea Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• South Korea Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Rest of APAC
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Rest of APAC Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Rest of APAC Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Rest of APAC Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Latin America
• Overview
• Key Manufacturers in Latin America
• Latin America Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
• Latin America Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Latin America Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Latin America Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Latin America Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Brazil
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Brazil Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Brazil Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Brazil Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Brazil Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Mexico
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Mexico Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Mexico Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Mexico Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Mexico Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Argentina
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Argentina Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Argentina Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Argentina Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Argentina Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Rest of LATAM
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Rest of LATAM Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Rest of LATAM Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Rest of LATAM Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Middle East and Africa
• Overview
• Key Manufacturers in Middle East and Africa
• Middle East and Africa Market Size and Forecast, By Country, 2016 – 2027 (US$ Million)
• Middle East and Africa Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Middle East and Africa Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Middle East and Africa Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• Saudi Arabia
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• Saudi Arabia Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• Saudi Arabia Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• Saudi Arabia Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
• United Arab Emirates
• Overview
• Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)
• United Arab Emirates Market Size and Forecast, By Type, 2016 – 2027 (US$ Million)
• United Arab Emirates Market Size and Forecast, By Treatment, 2016 – 2027 (US$ Million)
• United Arab Emirates Market Size and Forecast, By End-user, 2016 – 2027 (US$ Million)
• United Arab Emirates Market Size and Forecast, By Distribution Channel, 2016 – 2027 (US$ Million)
12. Key Vendor Analysis
• Competitive Dashboard
• Company Profiles( Companies are profiled based on attributes such as Company Overview, Financial Performance, Business Overview, Type Benchmarking and Strategic Developments)
• Sanofi
• GlaxoSmithKline Plc
• Biocon
• Novo Nordisk A/S
• Tonghua Dongbao Pharmaceutical Co., Ltd.
• Oramed Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Julphar
• Eli Lilly and Company
• Pfizer Inc.
• Adocia
• Hikma Pharmaceutical PLC
• Lupin Ltd.
• Wockhardt
• Zydus Pharmaceuticals Inc.
• AbbVie Inc.
• Glenmark
• Amneal pharmaceutical LLC
• Aurobindo Pharma
• Accord Healthcare
13. 360 Degree Analyst View
14. Appendix
• Research Methodology
• References
• Abbreviations
• Disclaimer
• Contact Us

List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Hypertriglyceridemia Market: Types Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Types
TABLE Global Hypertriglyceridemia Market, by Types 2016-2027 (USD Million)
TABLE Hypertriglyceridemia Market: Treatment Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Treatment
TABLE Global Hypertriglyceridemia Market, by Treatment 2016-2027 (USD Million)
TABLE Hypertriglyceridemia Market: End-user Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by End-user
TABLE Global Hypertriglyceridemia Market, by End-user 2016-2027 (USD Million)
TABLE Hypertriglyceridemia Market: Distribution Channel Snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
TABLE Global Hypertriglyceridemia Market, by Distribution Channel 2016-2027 (USD Million)
TABLE Hypertriglyceridemia Market: Regional snapshot (2019)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Hypertriglyceridemia Market, by Region 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by Country, 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by Types, 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by Treatment, 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by End-user, 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by Distribution Channel, 2016-2027 (USD Million)
TABLE Europe Hypertriglyceridemia Market, by Country, 2016-2027 (USD Million)
TABLE Europe Hypertriglyceridemia Market, by Types, 2016-2027 (USD Million)
TABLE Europe Hypertriglyceridemia Market, by Treatment, 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by End-user, 2016-2027 (USD Million)
TABLE North America Hypertriglyceridemia Market, by Distribution Channel, 2016-2027 (USD Million)
TABLE Asia Pacific Hypertriglyceridemia Market, by Country, 2016-2027 (USD Million)
TABLE Asia Pacific Hypertriglyceridemia Market, by Types, 2016-2027 (USD Million)
TABLE Asia Pacific Hypertriglyceridemia Market, by Treatment, 2016-2027 (USD Million)
TABLE Asia Pacific Hypertriglyceridemia Market, by End-user, 2016-2027 (USD Million)
TABLE Asia Pacific Hypertriglyceridemia Market, by Distribution Channel, 2016-2027 (USD Million)
TABLE Latin America Hypertriglyceridemia Market, by Country, 2016-2027 (USD Million)
TABLE Latin America Hypertriglyceridemia Market, by Type, 2016-2027 (USD Million)
TABLE Latin America Hypertriglyceridemia Market, by Treatment, 2016-2027 (USD Million)
TABLE Latin America Hypertriglyceridemia Market, by End-user, 2016-2027 (USD Million)
TABLE Latin America Hypertriglyceridemia Market, by Distribution Channel, 2016-2027 (USD Million)
TABLE Middle East and Africa Hypertriglyceridemia Market, by Country, 2016-2027 (USD Million)
TABLE Middle East and Africa Hypertriglyceridemia Market, by Type, 2016-2027 (USD Million)
TABLE Middle East and Africa Hypertriglyceridemia Market, by Treatment, 2016-2027 (USD Million)
TABLE Middle East and Africa Hypertriglyceridemia Market, by End-user, 2016-2027 (USD Million)
TABLE Middle East and Africa Hypertriglyceridemia Market, by Distribution Channel, 2016-2027 (USD Million)


List of Figures
FIGURE Hypertriglyceridemia Market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparison Study
FIGURE Competitive Landscape; Key company market share analysis, 2019
FIGURE Type segment market share analysis, 2020 & 2027
FIGURE Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Treatment segment market share analysis, 2020 & 2027
FIGURE Treatment segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE End-user segment market share analysis, 2020 & 2027
FIGURE End-user segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Distribution Channel segment market share analysis, 2020 & 2027
FIGURE Distribution Channel segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Regional segment market share analysis, 2020 & 2027
FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE North America Hypertriglyceridemia Market share and leading players, 2019
FIGURE Europe Hypertriglyceridemia Market share and leading players, 2019
FIGURE Asia Pacific Hypertriglyceridemia Market share and leading players, 2019
FIGURE Latin America Hypertriglyceridemia Market share and leading players, 2019
FIGURE Middle East and Africa Hypertriglyceridemia Market share and leading players, 2019
FIGURE North America market share analysis by country, 2019
FIGURE U.S. Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Canada Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Europe Hypertriglyceridemia Market share analysis by country, 2019
FIGURE Germany Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Spain Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Italy Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE UK Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE France Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of the Europe Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Asia Pacific Hypertriglyceridemia Market share analysis by country, 2019
FIGURE India Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE China Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Japan Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE South Korea Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Singapore Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of APAC Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Latin America Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Latin America Hypertriglyceridemia Market share analysis by country, 2019
FIGURE Brazil Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Mexico Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Argentina Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Rest of LATAM Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Middle East and Africa Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE Middle East and Africa Hypertriglyceridemia Market share analysis by country, 2019
FIGURE Saudi Arabia Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)
FIGURE United Arab Emirates Hypertriglyceridemia Market size, forecast and trend analysis, 2016 to 2027 (USD Million)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(AVEW21JN123 )"世界の高トリグリセリド血症市場2021年-2027年:種類別、治療別、エンドユーザー別、流通チャネル別、地域別" (英文:Hypertriglyceridemia Market with COVID-19 Impact Analysis, By Type, By Treatment, By End-user, By Distribution Channel, and By Region – Size, Share, & Forecast from 2021-2027)はAnalystView Market Insights社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。